Diagnos Laboratorium Utama Tbk. vs Nusantara Sawit Sejahtera Tbk. — how do they compare? Diagnos Laboratorium Utama Tbk. trades at Rp224 (market cap 310.75B, 963.6K 24h volume), while Nusantara Sawit Sejahtera Tbk. trades at Rp800 (market cap 18.45T, 10.52M 24h volume). The key difference: Nusantara Sawit Sejahtera Tbk. is far larger — about 59.4× Diagnos Laboratorium Utama Tbk.'s market cap, and Nusantara Sawit Sejahtera Tbk. is more actively traded (10.52M versus 963.6K). Which is the better fit depends on your goals.
| DGNS | NSSS | |
|---|---|---|
Market Cap | 310.75B | 18.45T |
Volume | 963.6K | 10.52M |
Lot | 9.64K | 105.24K |
Turnover | 217.67M | 8.34B |
Average Price | 225.89 | 792.82 |
Value | 217.67M | 8.34B |
Indicative Equilibrium Price | 226 | 800 |
Indicative Equilibrium Volume | 1K | 434 |
Trailing returns across standard periods
Latest headlines on both assets
PT Diagnos Laboratorium Utama Tbk (the “Company”) was established in the Republic of Indonesia on August 29, 2007 under framework of the Domestic Capital Investment Law No. 6 Year 1968 based on Deed No.17 dated August 29, 2007, of Martinef, S.H., M.Si., Notary in Bekasi. The Company started its commercial operation in 2008.
Read more on DGNS →PT Nusantara Sawit Sejahtera Tbk (the Company) was established based on the Notarial DeedNo. 01 and No. 14 of Engawati Gazali, S.H., dated April 1, 2009 and June 12, 2009, respectively, and has been approved by the Minister of Law and Human Rights of the Republic of Indonesia in its Decision Letter No. AHU-28662.AH.01.01 dated June 26, 2009. The Company started its commercialoperations in 2020.
Read more on NSSS →